Annual EBITDA:
-$286.21M+$135.55M(+32.14%)Summary
- As of today, LEGN annual EBITDA is -$286.21 million, with the most recent change of +$135.55 million (+32.14%) on December 31, 2024.
- During the last 3 years, LEGN annual EBITDA has risen by +$93.87 million (+24.70%).
- LEGN annual EBITDA is now -2144.66% below its all-time high of $14.00 million, reached on December 1, 2017.
Performance
LEGN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$113.72M-$24.85M(-27.96%)Summary
- As of today, LEGN quarterly EBITDA is -$113.72 million, with the most recent change of -$24.85 million (-27.96%) on June 30, 2025.
- Over the past year, LEGN quarterly EBITDA has dropped by -$106.61 million (-1497.89%).
- LEGN quarterly EBITDA is now -316.78% below its all-time high of $52.46 million, reached on December 31, 2024.
Performance
LEGN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$260.04M-$106.61M(-69.48%)Summary
- As of today, LEGN TTM EBITDA is -$260.04 million, with the most recent change of -$106.61 million (-69.48%) on June 30, 2025.
- Over the past year, LEGN TTM EBITDA has dropped by -$17.05 million (-7.01%).
- LEGN TTM EBITDA is now -2101.52% below its all-time high of -$11.81 million, reached on March 31, 2019.
Performance
LEGN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LEGN EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +32.1% | -1497.9% | -7.0% |
3Y3 Years | +24.7% | +40.6% | +42.1% |
5Y5 Years | -117.2% | +15.6% | +15.4% |
LEGN EBITDA Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | at high | +34.9% | -316.8% | +39.8% | -129.8% | +47.5% |
5Y | 5-Year | -117.2% | +34.9% | -316.8% | +40.6% | -129.8% | +47.5% |
All-Time | All-Time | -2144.7% | +34.9% | -316.8% | +40.6% | -2101.5% | +47.5% |
LEGN EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$113.72M(-28.0%) | -$260.04M(-69.5%) |
Mar 2025 | - | -$88.87M(-269.4%) | -$153.44M(-35.6%) |
Dec 2024 | -$286.21M(+32.1%) | $52.46M(+147.7%) | -$113.16M(+62.4%) |
Sep 2024 | - | -$109.91M(-1444.3%) | -$301.26M(-24.0%) |
Jun 2024 | - | -$7.12M(+85.4%) | -$243.00M(+42.8%) |
Mar 2024 | - | -$48.59M(+64.2%) | -$424.79M(+11.1%) |
Dec 2023 | -$421.76M(+4.1%) | -$135.64M(-162.6%) | -$477.87M(-2.1%) |
Sep 2023 | - | -$51.65M(+72.7%) | -$467.85M(+5.0%) |
Jun 2023 | - | -$188.91M(-85.8%) | -$492.64M(+0.5%) |
Mar 2023 | - | -$101.68M(+19.1%) | -$495.17M(-16.6%) |
Dec 2022 | -$439.66M(-15.7%) | -$125.61M(-64.3%) | -$424.57M(-5.1%) |
Sep 2022 | - | -$76.45M(+60.1%) | -$403.96M(+10.1%) |
Jun 2022 | - | -$191.43M(-515.9%) | -$449.20M(-28.6%) |
Mar 2022 | - | -$31.08M(+70.4%) | -$349.31M(+15.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$380.08M(-72.5%) | -$105.01M(+13.7%) | -$412.79M(-12.1%) |
Sep 2021 | - | -$121.69M(-32.9%) | -$368.39M(-17.4%) |
Jun 2021 | - | -$91.53M(+3.2%) | -$313.67M(+12.1%) |
Mar 2021 | - | -$94.56M(-56.0%) | -$356.93M(-16.5%) |
Dec 2020 | -$220.32M(-67.2%) | -$60.61M(+9.5%) | -$306.31M(+0.3%) |
Sep 2020 | - | -$66.96M(+50.3%) | -$307.30M(-14.6%) |
Jun 2020 | - | -$134.79M(-206.7%) | -$268.04M(-65.8%) |
Mar 2020 | - | -$43.95M(+28.7%) | -$161.70M(-24.8%) |
Dec 2019 | -$131.79M(-858.5%) | -$61.60M(-122.3%) | -$129.57M(-90.6%) |
Sep 2019 | - | -$27.71M(+2.6%) | -$67.97M(-68.8%) |
Jun 2019 | - | -$28.45M(-140.8%) | -$40.26M(-240.8%) |
Mar 2019 | - | -$11.81M | -$11.81M |
Dec 2018 | -$13.75M(-198.2%) | - | - |
Dec 2017 | $14.00M | - | - |
FAQ
- What is Legend Biotech Corporation annual EBITDA?
- What is the all-time high annual EBITDA for Legend Biotech Corporation?
- What is Legend Biotech Corporation annual EBITDA year-on-year change?
- What is Legend Biotech Corporation quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Legend Biotech Corporation?
- What is Legend Biotech Corporation quarterly EBITDA year-on-year change?
- What is Legend Biotech Corporation TTM EBITDA?
- What is the all-time high TTM EBITDA for Legend Biotech Corporation?
- What is Legend Biotech Corporation TTM EBITDA year-on-year change?
What is Legend Biotech Corporation annual EBITDA?
The current annual EBITDA of LEGN is -$286.21M
What is the all-time high annual EBITDA for Legend Biotech Corporation?
Legend Biotech Corporation all-time high annual EBITDA is $14.00M
What is Legend Biotech Corporation annual EBITDA year-on-year change?
Over the past year, LEGN annual EBITDA has changed by +$135.55M (+32.14%)
What is Legend Biotech Corporation quarterly EBITDA?
The current quarterly EBITDA of LEGN is -$113.72M
What is the all-time high quarterly EBITDA for Legend Biotech Corporation?
Legend Biotech Corporation all-time high quarterly EBITDA is $52.46M
What is Legend Biotech Corporation quarterly EBITDA year-on-year change?
Over the past year, LEGN quarterly EBITDA has changed by -$106.61M (-1497.89%)
What is Legend Biotech Corporation TTM EBITDA?
The current TTM EBITDA of LEGN is -$260.04M
What is the all-time high TTM EBITDA for Legend Biotech Corporation?
Legend Biotech Corporation all-time high TTM EBITDA is -$11.81M
What is Legend Biotech Corporation TTM EBITDA year-on-year change?
Over the past year, LEGN TTM EBITDA has changed by -$17.05M (-7.01%)